A phase Ib, double-blind, randomized, dose-cohort escalation study of intravenous PRO 140 [PRO-140] or placebo in adult patients with HIV-1 infection

Trial Profile

A phase Ib, double-blind, randomized, dose-cohort escalation study of intravenous PRO 140 [PRO-140] or placebo in adult patients with HIV-1 infection

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Oct 2008

At a glance

  • Drugs PRO 140 (Primary)
  • Indications HIV infections; HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Progenics Pharmaceuticals
  • Most Recent Events

    • 03 Oct 2008 Results published in the Journal of Infectious Diseases in November 2008.
    • 05 May 2008 Status change
    • 15 Feb 2008 Added sponsor and investigator from Current Controlled Trials record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top